Skip to main content
RNGE logo

RNGE · Range Impact, Inc. · Shareholders & Ownership

Track RNGE — free
$0.53 -0.02 (-4.18%) At close · Oct 20
Market Cap
$65.03M
Shares
122.69M
Volume · Oct 20 44.13K Avg daily vol (3M) 28.78K

Every disclosed holder of RNGE in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns RNGE

13F quarter Sep 30, 2025
Holder group Shares % Out
Institutional (13F) 84,560 0.07%
Insiders (Forms 3, 4, 5) 8,477,933 6.91%
13D/G-only blocks 21,333,333 17.39%
Remaining 92,795,929 75.63%
Registered funds (N-PORT, not summed) 0 0.00%

Shares outstanding: 122,691,755, the issuer's latest cover-page count restated onto today's split basis.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of RNGE

# Holder Shares
1
Indemnity National Insurance Company
13G CIK 1929794 · Insurance company · Oct 30, 2023
Rule 13d-1(b), qualified institution
21,333,333
2
FEIGHAN EDWARD F
Insider CIK 1068614 · Sep 23, 2025
Director, issuer-wide
4,417,584
3
Cavanaugh Michael R.
Insider CIK 1757622 · Sep 23, 2025
Director, Chief Executive Officer, issuer-wide
2,546,458
4
LoConti Joseph E.
Insider CIK 1025708 · Sep 23, 2025
10% Owner, issuer-wide
1,263,891
5
Celeste Richard F
Insider CIK 1412038 · Jun 15, 2026
Director, issuer-wide
250,000
6
KLCM Advisors, Inc.
13F CIK 1166620 · Investment adviser · Sep 30, 2025
74,000
7
Ancora Advisors LLC
13F CIK 1446114 · Registered investment adviser · Sep 30, 2025
10,560

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 1438943 CUSIP 56089M107 Visit website Investor relations